Story thread · 4 reports / 1 sources
NYU Langone, Dana-Farber co-develop oncology platform
beckershospitalreview.com · 12d
How the coverage leans
Across 1 sources · syndicated copies counted once
New York City-based NYU Langone Health and Boston-based Dana-Farber Cancer Institute launched Solavia Decision Suite, an oncology decision support platform embedded directly in the electronic health record. The tool went live internally at NYU Langone on June 30 and is now commercially available to other health systems. The two institutions co-developed Solavia to give physicians […] The post NYU Langone, Dana-Farber co-develop oncology platform appeared first on Becker's Hospital Review | Healthcare News & Analysis .
First report: UHS posts 11.1% operating margin, trims 2026 forecast — beckershospitalreview.com, 15d
The conversation · 0
Sign in to join the conversation.
No comments yet — start the thread.